Literature DB >> 1719130

Activation of cellular oncogenes by clinical isolates and laboratory strains of human cytomegalovirus.

I Boldogh1, S AbuBakar, M P Fons, C Z Deng, T Albrecht.   

Abstract

The effect on cellular (c) oncogene RNA levels was investigated after infection of permissive cells with cell culture adapted strains (AD-169, C-87, Davis) and unadapted clinical isolates (82-1, 84-2, 85-1) of human cytomegalovirus (HCMV). The results indicate that both adapted and unadapted strains of HCMV induce substantial increases in c-oncogene RNA levels for fos, jun, and myc measured by Northern blot hybridization. Elimination of immediate early (IE) protein synthesis between 0 and 3 hrs or reduction of virus infectivity (99.99%) by UV-irradiation did not reduce the increase in c-oncogene RNA levels. Inhibition of viral and cellular protein synthesis by cycloheximide resulted in a high abundance (superinduction) of specific RNAs which hybridized to c-oncogene probes after infection with either adapted or unadapted strains of HCMV. These data suggest that IE viral gene expression is not essential for activation of c-oncogenes. Inhibition of DNA-dependent RNA synthesis by blocking RNA elongation with actinomycin-D or by inhibiting the activity of RNA polymerase II with alpha-amanitin significantly reduced the increase in c-oncogene RNA levels, suggesting that activation of cellular genes by HCMV is controlled at the level of transcription. Activation of c-oncogenes by HCMV may be particularly important because their protein products appear to be involved in initiation and regulation of viral and cellular gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719130     DOI: 10.1002/jmv.1890340409

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.

Authors:  Afsar Rahbar; Madeleine Cederarv; Nina Wolmer-Solberg; Charlotte Tammik; Giuseppe Stragliotto; Inti Peredo; Olesja Fornara; Xinling Xu; Mensur Dzabic; Chato Taher; Petra Skarman; Cecilia Söderberg-Nauclér
Journal:  Oncoimmunology       Date:  2015-08-24       Impact factor: 8.110

2.  The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection.

Authors:  J A Kerry; M A Priddy; T L Staley; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 3.  Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Authors:  J Doniger; S Muralidhar; L J Rosenthal
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

4.  Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection.

Authors:  M A Billstrom; G L Johnson; N J Avdi; G S Worthen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.

Authors:  Rodney Arcenas; Raymond H Widen
Journal:  BMC Microbiol       Date:  2002-07-23       Impact factor: 3.605

6.  Modulation of Radiation-Induced Genetic Damage by HCMV in Peripheral Blood Lymphocytes from a Brain Tumor Case-Control Study.

Authors:  Elizabeth A Rourke; Mirtha S Lopez; Claudia M Monroy; Michael E Scheurer; Carol J Etzel; Thomas Albrecht; Melissa L Bondy; Randa A El-Zein
Journal:  Cancers (Basel)       Date:  2010-04-12       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.